CREATE Health - Translational Cancer Center

CREATE Health is a Strategic Centre for Translational Cancer research mainly located at Medicon Village in Lund. CREATE Health aims to provide individualized and improved therapeutic strategies, based on our ability to determine which patient will benefit from a particular treatment. CREATE Health provides solutions to clinical problems by developing innovative diagnostic and therapeutic ideas , for the benefit of the patients and society. Our approach is translational - It starts from a specific need, identified by our clinical partners. We use novel technological approaches to find the relevant solutions, which can be implemented into the clinic with much shorter lead times. In 2025, CREATE Health Translational Cancer Center received a donation from the Mrs Berta Kamprad’s Cancer Foundation of 420 million SEK. This is the single largest donation to Lund University, since its founding in 1666. The funds are distributed over a five-year period and dedicated to translational cancer research within the L2CancerBridge program. Other main funding has been provided by the Swedish Foundation for Strategic Research, Knut and Alice Wallenberg Foundation and VINNOVA. By integrating clinicians and researchers from Lund University Hospital with researchers from the Faculties of Medicine, Natural Sciences and Engineering using a superbly equipped and integrated “omics” platform, concentrated in a single area, a centre unique in its kind has been created. The vision of CREATE Health is to use an integrative approach to develop novel diagnostics and therapeutics, based on identified markers and molecular signatures and to create a substantial social impact for the patient, through direct application of research for selection of an optimal, individually-based, cancer treatment.